High and intermediate grade ductal carcinoma in-situ of the breast: A comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision

Diagnostic Pathology

Volumn 4, Issue 1, 2009, Pages

  Fadare, Oluwole ^a,b   Clement, Nathan F ^a,c,d   Ghofrani, Mohiedean ^e  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d San Antonio Uniformed Services Health Education Consortium   (United States)

^e Southwest Washington Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350504614     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-4-26     Document Type: Article

References (66)

1. Ductal carcinoma in situ in breast carcinogenesis. PJ van Diest, J Pathol 1999 187 383 4 10.1002/(SICI)1096-9896(199903)187:4<383::AID-PATH2993.0. CO;2-H 10398095
2. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. JS Reis-Filho SR Lakhani, Breast Cancer Res 2003 5 313 9 10.1186/bcr650 14580249
3. Incidence of and treatment for ductal carcinoma in situ of the breast. VL Ernster J Barclay K Kerlikowske D Grady C Henderson, JAMA 1996 275 913 8 10.1001/jama.275.12.913 8598618
4. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. SA Joslyn, Breast J 2006 12 20 7 10.1111/j.1075-122X.2006.00182.x 16409583
5. Detection of ductal carcinoma in situ in women undergoing screening mammography. VL Ernster R Ballard-Barbash WE Barlow Y Zheng DL Weaver G Cutter BC Yankaskas R Rosenberg PA Carney K Kerlikowske SH Taplin N Urban BM Geller, J Natl Cancer Inst 2002 94 1546 54 12381707
6. Results of 23,810 cases of ductal carcinoma-in-situ. WE Sumner 3rd LG Koniaris SE Snell S Spector J Powell E Avisar F Moffat AS Livingstone D Franceschi, Ann Surg Oncol 2007 14 1638 43 10.1245/s10434-006-9316-1 17245612
7. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. LN van Steenbergen AC Voogd JA Roukema WJ Louwman LE Duijm JW Coebergh LV van de Poll-Franse, Breast Cancer Res Treat 2009 115 181 3 10.1007/s10549-008-0067-5 18516674
8. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening. C Luke K Priest D Roder, Asian Pac J Cancer Prev 2006 7 69 74 16629519
9. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. S Hofvind R Sørum S Thoresen, Acta Oncol 2008 47 225 31 10.1080/02841860701518041 17851868
10. Molecular genetics of ADH/DCIS and ALH/LCIS. JS Reis-Filho SR Lakhani, Breast Pathology Philadelphia: Churchill Livingstone Elsevier, O'Malley FP, Pinder SE, 2006 185 9
11. Molecular evolution of breast cancer. PT Simpson JS Reis-Filho T Gale SR Lakhani, J Pathol 2005 205 248 54 10.1002/path.1691 15641021
12. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. AS Leong RT Sormunen S Vinyuvat RW Hamdani C Suthipintawong, Am J Clin Pathol 2001 115 709 18 10.1309/WBU9-22QN-C3NA-2Q12 11345835
13. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. JS Reis-Filho PT Simpson T Gale SR Lakhani, Pathol Res Pract 2005 201 713 25 10.1016/j.prp.2005.05.013 16325514
14. Current controversies in the treatment of ductal carcinoma in situ of the breast. G Franceschini D Terribile S Magno C Fabbri P D'Alba F Chiesa A Di Leone I Scafetta R Masetti, Ann Ital Chir 2008 79 151 5 18958961
15. The management of ductal carcinoma in situ of the breast: a screened population-based analysis. E Rakovitch JP Pignol C Chartier W Hanna H Kahn J Wong V Mai L Paszat, Breast Cancer Res Treat 2007 101 335 47 10.1007/s10549-006-9302-0 16838110
16. Controversies over the role of radiation therapy for ductal carcinoma in situ. BD Smith GL Smith TA Buchholz, Expert Rev Anticancer Ther 2008 8 433 41 10.1586/14737140.8.3.433 18366290
17. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. CH van Deurzen MG Hobbelink R van Hillegersberg PJ van Diest, Eur J Cancer 2007 43 993 1001 10.1016/j.ejca.2007. 01.010 17300928
18. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. CW Elston IO Ellis, Histopathology 1991 19 403 10 10.1111/j.1365-2559.1991.tb00229.x 1757079
19. Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma in situ in breast excision specimens. F Dadmanesh X Fan A Dastane MB Amin S Bose, Arch Pathol Lab Med 2009 133 26 30 19123732
20. Impact of core biopsy on the management of screen-detected ductal carcinoma in situ of the breast. MS Cheng J Fox SA Hart, ANZ J Surg 2003 73 404 6 10.1046/j.1445-2197.2003.t01-1-02656.x 12801338
21. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. LL Fajardo ED Pisano DJ Caudry CA Gatsonis WA Berg J Connolly S Schnitt DL Page BJ McNeil Radiologist Investigators of the Radiologic Diagnostic Oncology Group V, Acad Radiol 2004 11 293 308 10.1016/S1076-6332(03)00510-5 15035520
22. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice. MF Dillon CM Quinn EW McDermott A O'Doherty N O'Higgins AD Hill, J Clin Pathol 2006 59 740 3 10.1136/jcp.2005.034330 16803949
23. Analysis of cancers not diagnosed at stereotactic core breast biopsy. L Liberman DD Dershaw JR Glassman AF Abramson EA Morris LR LaTrenta PP Rosen, Radiology 1997 203 151 7 9122384
24. Predictive value of extent and grade of ductal carcinoma in situ in radiologically guided core biopsy for the status of margins in lumpectomy specimens. KT Mai HM Yazdi JC Ford FR Matzinger, Eur J Surg Oncol 2000 26 646 51 10.1053/ejso.2000.0975 11078610
25. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. M Dzierzanowski KA Melville PJ Barnes RF MacIntosh JS Caines GA Porter, J Surg Oncol 2005 90 71 6 10.1002/jso.20242 15844190
26. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. RE Jimenez S Bongers D Bouwman M Segel DW Visscher, Am J Surg Pathol 2000 24 123 8 10.1097/00000478-200001000-00015 10632496
27. Needle core biopsy characteristics identify patients at risk of compromised margins in breast conservation surgery. MF Dillon AA Maguire EW McDermott C Myers AD Hill A O'Doherty CM Quinn, Mod Pathol 2008 21 39 45 10.1038/modpathol.3800975 17948023
28. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough? K von Smitten, J Surg Oncol 2008 98 585 7 10.1002/jso.21038 19072849
29. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. P Meijnen HS Oldenburg JL Peterse H Bartelink EJ Rutgers, Ann Surg Oncol 2008 15 235 43 10.1245/s10434-007-9659-2 17987342
30. Factors affecting successful breast conservation for ductal carcinoma in situ. MF Dillon EW Mc Dermott A O'Doherty CM Quinn AD Hill N O'Higgins, Ann Surg Oncol 2007 14 1618 28 10.1245/s10434-006-9246-y 17443388
31. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. L Cheng NK Al-Kaisi NH Gordon AY Liu F Gebrail RR Shenk, J Natl Cancer Inst 1997 89 1356 60 10.1093/jnci/89.18.1356 9308705
32. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. AC Neuschatz T DiPetrillo M Steinhoff H Safaii M Yunes M Landa M Chung B Cady DE Wazer, Cancer 2002 94 1917 24 10.1002/cncr.10460 11932892
33. Close or positive margins after mastectomy for DCIS: pattern of relapse and potential indications for radiotherapy. A Rashtian S Iganej IL Amy Liu S Natarajan, Int J Radiat Oncol Biol Phys 2008 72 1016 20 18954711
34. Residual disease after re-excision lumpectomy for close margins. MS Sabel K Rogers K Griffith R Jagsi CG Kleer KA Diehl TM Breslin VM Cimmino AE Chang LA Newman, J Surg Oncol 2009 99 99 103 10.1002/jso.21215 19065638
35. Breast specimen ultrasound and mammography in the prediction of tumour-free margins. KY Tan SM Tan SH Chiang A Tan CK Chong KH Tay, ANZ J Surg 2006 76 1064 7 10.1111/j.1445-2197.2006.03941.x 17199691
36. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. N Cabioglu KK Hunt AA Sahin HM Kuerer GV Babiera SE Singletary GJ Whitman MI Ross FC Ames BW Feig TA Buchholz F Meric-Bernstam, Ann Surg Oncol 2007 14 1458 71 10.1245/s10434-006-9236-0 17260108
37. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. A Chagpar T Yen A Sahin KK Hunt GJ Whitman FC Ames MI Ross F Meric-Bernstam GV Babiera SE Singletary HM Kuerer, Am J Surg 2003 186 371 7 10.1016/S0002-9610(03)00264-2 14553853
38. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. TP Olson J Harter A Mũoz DM Mahvi T Breslin, Ann Surg Oncol 2007 14 2953 60 17674109
39. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. D Cao C Lin SH Woo R Vang TN Tsangaris P Argani, Am J Surg Pathol 2005 29 1625 32 10.1097/01.pas.0000180448. 08203.70 16327435
40. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation. G Hermann RJ Keller S Drossman BA Caravella P Tartter RA Panetta IJ Bleiweiss, Can Assoc Radiol J 1999 50 235 40 10459309
41. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. B Barreau I de Mascarel C Feuga G MacGrogan MH Dilhuydy V Picot JM Dilhuydy CT de Lara E Bussières I Schreer, Eur J Radiol 2005 54 55 61 10.1016/j.ejrad.2004.11.019 15797293
42. Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ? HP Dinkel AM Gassel A Tschammler, Br J Radiol 2000 73 938 44 11064645
43. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. R Holland JH Hendriks AL Vebeek M Mravunac JH Schuurmans Stekhoven, Lancet 1990 335 519 22 10.1016/0140-6736(90)90747-S 1968538
44. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. R Holland JH Hendriks, Semin Diagn Pathol 1994 11 181 92 7831529
45. Ductal carcinoma in situ: state of the science and roadmap to advance the field. HM Kuerer CT Albarracin WT Yang RD Cardiff AM Brewster WF Symmans NM Hylton LP Middleton S Krishnamurthy GH Perkins G Babiera ME Edgerton BJ Czerniecki BK Arun GN Hortobagyi, J Clin Oncol 2009 27 279 88 10.1200/JCO.2008.18.3103 19064970
46. Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast. C Constantine P Parhar S Lymberis M Fenton-Kerimian SC Han BS Rosenstein SC Formenti, Clin Breast Cancer 2008 8 269 74 10.3816/CBC.2008.n.031 18650158
47. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. DE Schiller LW Le BC Cho BJ Youngson DR McCready, Ann Surg Oncol 2008 15 833 42 10.1245/s10434-007-9711-2 18163174
48. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. NS Goldstein L Kestin F Vicini, Am J Surg Pathol 1999 23 1340 8 10.1097/00000478-199911000-00004 10555002
49. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy. NS Goldstein L Kestin F Vicini, Am J Surg Pathol 2000 24 1058 67 10.1097/00000478-200008000-00003 10935646
50. Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations. I de Mascarel F Bonichon G MacGrogan CT de Lara A Avril V Picot M Durand L Mauriac M Trojani JM Coindre, Breast Cancer Res Treat 2000 61 151 9 10.1023/A:1006437902770 10942101
51. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. FA Vicini LL Kestin NS Goldstein KL Baglan JE Pettinga AA Martinez, J Surg Oncol 2001 76 245 54 10.1002/jso.1041 11320515
52. Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy. EA O'Flynn JC Morel J Gonzalez N Dutt D Evans R Wasan MJ Michell, Clin Radiol 2009 64 178 83 10.1016/j.crad.2008.08.007 19103348
53. Predicting invasion in patients with DCIS in the preoperative percutaneous biopsy. J Leikola P Heikkilä M Pamilo K Salmenkivi K Von Smitten M Leidenius, Acta Oncol 2007 46 798 802 10.1080/02841860601128941 17653903
54. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. LA Rutstein RR Johnson WR Poller D Dabbs J Groblewski T Rakitt A Tsung T Kirchner J Sumkin D Keenan A Soran G Ahrendt JS Falk, Breast J 2007 13 251 7 10.1111/j.1524-4741.2007.00418.x 17461899
55. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. TW Yen KK Hunt MI Ross NQ Mirza GV Babiera F Meric-Bernstam SE Singletary WF Symmans SH Giordano BW Feig FC Ames HM Kuerer, J Am Coll Surg 2005 200 516 26 10.1016/j.jamcollsurg. 2004.11.012 15804465
56. Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study. U Kettritz K Rotter I Schreer M Murauer R Schulz-Wendtland D Peter SH Heywang-Köbrunner, Cancer 2004 100 245 51 10.1002/cncr.11887 14716757
57. The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes. R Sakr C Bezu I Raoust M Antoine F Ettore J Darcourt K Kerrou E Dara R Rouzier S Uzan, Int J Clin Pract 2008 62 1730 5 10.1111/j.1742-1241.2008.01867.x 19143859
58. Predicting invasion in mammographically detected microcalcification. MJ Bagnall AJ Evans AR Wilson SE Pinder H Denley JG Geraghty IO Ellis, Clin Radiol 2001 56 828 32 10.1053/crad.2001.0779 11895299
59. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. A Maffuz S Barroso-Bravo I Njera G Zarco I Alvarado-Cabrero SA Rodríguez-Cuevas, J Exp Clin Cancer Res 2006 25 223 7 16918134
60. Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis). EA Rakha ME El-Sayed J Reed AH Lee AJ Evans IO Ellis, Eur J Cancer 2009 45 1162 7 10.1016/j.ejca.2008.12.002 19121932
61. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. CH van Deurzen MG Hobbelink R van Hillegersberg PJ van Diest, Eur J Cancer 2007 43 993 1001 10.1016/j.ejca.2007. 01.010 17300928
62. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. B Ansari SA Ogston CA Purdie DJ Adamson DC Brown AM Thompson, Br J Surg 2008 95 547 54 10.1002/bjs.6162 18386775
63. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. K Polom D Murawa J Wasiewicz W Nowakowski P Murawa, Eur J Surg Oncol 2009 35 43 7 18723312
64. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. C Tunon-de-Lara S Giard M Buttarelli J Blanchot JM Classe M Baron B Monnier G Houvenaeghel, Breast J 2008 14 135 40 10.1111/j.1524-4741.2007.00543.x 18315691
65. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. A Goyal A Douglas-Jones I Monypenny H Sweetland G Stevens RE Mansel, Breast Cancer Res Treat 2006 98 311 4 10.1007/s10549-006- 9167-2 16552627
66. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of DCIS is it justified? B Doyle M Al-Mudhaffer MM Kennedy A O'Doherty F Flanagan EW McDermot MJ Kerin AD Hill CM Quinn, J Clin Pathol 2009 62 534 8 10.1136/jcp.2008.061457 19190009